Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Activities

Activities per year 2018 2018 2018

• 1 Participation in conference
• 1 Talk or presentation at a conference

Activities per year

Search results

• Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

  Gil Awada (Speaker), Ibrahim Özdemir (Contributor), Julia Katharina Schwarze (Contributor), Emma Daeninck (Contributor), Odrade Gondry (Contributor), Yanina Jansen (Contributor), Teofila Seremet (Contributor), Marleen Keyaerts (Contributor), Hendrik Everaert (Contributor) & Bart Neyns (Contributor)

  14 Dec 2018

  Activity: Talk or presentation › Talk or presentation at a conference

• ESMO Immuno-Oncology Congress 2018

  Marleen Keyaerts (Participant)

  13 Dec 2018 → 16 Dec 2018

  Activity: Participating in or organising an event › Participation in conference